UK Biobank Analysis Ties Top Quintile GlycA to 43% Higher Heart Attack and Stroke Risk via Cardiac Remodeling

Researchers examined nearly 480,000 UK Biobank participants using GlycA, cardiac MRI, and genetic instruments. Higher inflammation correlated with socioeconomic disadvantage, psychological distress, smoking, and adiposity; these factors preceded measurable structural changes that appeared years before clinical events. The study identified IL-1 and TNF pathway proteins as probable mediators, consistent with prior interventional data from the CANTOS trial that reduced events by targeting IL-1eta.

Chronic stress operates through sustained low-grade immune activation that accelerates myocardial fibrosis and impairs diastolic filling. This pathway links everyday psychosocial burdens to objective cardiac phenotypes, extending beyond traditional risk-factor models and highlighting why purely behavioral interventions may underperform in disadvantaged populations.

Several IL-1 and TNF inhibitors already in cardiovascular outcome trials could be repurposed for high-GlycA subgroups. Future work must test whether lowering GlycA with these agents or with targeted social interventions alters hard endpoints and reverses early remodeling.

Next steps require randomized evaluation of anti-inflammatory therapy stratified by GlycA in primary prevention cohorts, with five-year follow-up to assess reversal of MRI-detected changes.